Purpose: To examine behavioral factors that lead patients to consider quitting smoking and features associated with readiness to quit among adults who are seeking treatment in the emergency department (ED) for respiratory symptoms.
Methods: A toal of 665 adult smokers seeking treatment in an ED for respiratory symptoms and respiratory illness answered survey questions during the ED visit.
Results: Patients self-reported "readiness to quit" was broadly distributed among this patient population. Patients with COPD, pneumonia or asthma perceived higher risks from smoking than other patients with respiratory complaints. Over half of all participants had scores indicative of depression. Regression analysis showed that prior efforts to quit, confidence, perceived importance of quitting and decisional balance were each significantly predictive of readiness to quit, accounting for 40% of the variance.
Conclusions: While many of these patients appear unaware of the connection between their symptoms and their smoking, patients with diagnosed chronic respiratory illness perceived higher risks from their smoking. In patients who do not perceive these risks, physician intervention may increase perceived risk from smoking and perceived importance of quitting. Interventions designed for the ED setting targeting this patient population should consider screening for depressive symptoms and, when appropriate, making referrals for further evaluation and/or treatment. Medications that can help alleviate depression and withdrawal symptoms while quitting smoking, such as bupropion, may be particularly useful for this subset of patients, as depression is a substantial barrier to quitting.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120652 | PMC |
http://dx.doi.org/10.1186/1865-1380-4-24 | DOI Listing |
Can J Psychiatry
January 2025
Division of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Objective: Tobacco smoking is the leading cause of preventable death among individuals with serious mental illness (SMI) but few persons with SMI are offered smoking cessation treatment. The purpose of this study was to pilot-test a multicomponent intervention to increase the delivery of evidence-based smoking cessation treatment in community mental health clinics (CMHCs).
Method: This study was carried out at five CMHCs in Maryland involving clinicians who participated in training in smoking cessation.
Objective: The present research evaluated the impact of legalizing recreational cannabis among individuals with substance use disorders (SUDs) who may already use cannabis at high rates.
Method: Using an interrupted time series study design, we evaluated the potential impact of legalizing recreational cannabis among individuals seeking treatment for SUD within a hospital-based treatment setting in Guelph, Ontario. We examined 2,925 individuals who entered an inpatient SUD treatment program between April 2017 and December 2021.
J Ethn Subst Abuse
January 2025
Department of Psychiatry, JSS Academy of Higher Education and Research, and JSS Medical College and Hospital, Mysore, India.
Background: Due to a lack of awareness and inadequate health infrastructure, the treatment gap for any mental illness is increasing in lower- and middle-income countries, including India. As an alternative to institutional treatment, community de-addiction camps play an important role.
Method: This comparative study examined alcohol use profiles, motivation to quit, and attitudes toward drinking in 84 participants, equally divided between a community alcohol de-addiction camp ( = 42) and a clinical setting ( = 42).
Cureus
November 2024
Department of Public Health Sciences, Penn State University College of Medicine, Milton S. Hershey Medical Center, Hershey, USA.
Background The effects of tobacco use create a significant burden on the American healthcare system. The U.S.
View Article and Find Full Text PDFTob Use Insights
December 2024
University Center for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland.
Medications for smoking cessation can double quit rates but are underused in primary care. This qualitative study aimed to explore: (1) patients' perspectives regarding having their general practitioner (GP) use a proactive approach to smoking cessation treatment using an encounter decision aid (DA), and (2) their expectations regarding their GP's role. We conducted qualitative semi-structured interviews with participants of the FIRST randomized trial (adults who smoke daily with any level of motivation for tobacco quitting).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!